The Use of "O" Shaped- Endotracheal Tube During Intubation for General Anesthesia: Prospective Randomized Trial

August 18, 2020 updated by: Yu-Kyung Bae, Seoul National University Hospital
This study is prospective randomized trial study. "O" type tracheal intubation tube is anatomically consistent and will able to increase the success rate of first intubation without any other external help.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

This study is divided into two groups. : control vs. "O" shape endotracheal tube.

The investigator was studied 238 consecutive the American Society of Anesthesiologists' physical grades I and II adult patients scheduled to undergo general anesthesia requiring tracheal intubation for elective surgery. Exclusion criteria included a gross anatomical abnormality, before surgery of the head, neck and cervical spine, previously difficult tracheal intubation, loose teeth, or those requiring a rapid sequence or awake intubation, moderate or severe obstructive/restrictive pulmonary disease accompanied by pulmonary function tests. Anesthesia was induced with remifentanyl 3ng/kg, propopol 1-2 mg/kg or TIVA 2% fresopol 4ug/dL, remifentanyl 3ng/dL and rocuronium 0.8 mg/kg to facilitate tracheal intubation. Laryngoscopy was performed after the loss of the fourth twitch in the train-of-four in response to ulnar nerve stimulation. All laryngoscopies using a #4 Macintosh blade were performed with the patient placed in the sniffing position. Tracheal intubation was performed without assistance (ex. External laryngeal manipulation, Used stylet). A single experienced anesthesiologist, blinded to each group, performed all of the direct laryngoscopies and classified the laryngoscopic view according to the modified Cormack and Lehane grade, measured number of attempts, intubation time and blood pressure and heart rate before/ after intubation.

Study Type

Interventional

Enrollment (Anticipated)

238

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Gyeongggi-do
      • Seongnam-si, Gyeongggi-do, Korea, Republic of, 13620
        • Recruiting
        • Seoul National University Bundang Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Consented to participate in the study
  • Aged 19 years or older
  • The American Society of Anesthesiologists' physical grades I and II
  • Undergo elective surgery under general anesthesia

Exclusion Criteria:

  • Do not agree to participate in research
  • Previously difficult tracheal intubation
  • Rapid induction of anesthesia
  • Previous c-spine disc or had surgery
  • Teeth are severely shaken or poor
  • Moderate or severe obstructive/restrictive pulmonary disease accompanied by pulmonary function tests

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control
Use in the shape of an endotracheal tube.
EXPERIMENTAL: Group "O"
Just before the induction of medicine is injected, the assistant makes endotracheal tube into "O" shape.
Endotracheal tube was made "O" shape by assistants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First intubation success rate for each between two group
Time Frame: Immediately after intubation
First laryngoscope tries was success using detection of end tidal CO2
Immediately after intubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First intubation time
Time Frame: within 60 seconds
After intubation, appearing end tidal CO2 at monitoring
within 60 seconds
Number of attempts
Time Frame: From the first tracheal intubation failure to the next successful tracheal intubation
Number of intubation try
From the first tracheal intubation failure to the next successful tracheal intubation
Measured vital sign
Time Frame: immediately before intubation and within 5 minites after intubation
Blood pressure in mmHg and heart rate in bpm were recorded immediately before and after intubation.
immediately before intubation and within 5 minites after intubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu-Kyung Bae, Seoul National University Bundang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 24, 2020

Primary Completion (ANTICIPATED)

March 31, 2022

Study Completion (ANTICIPATED)

March 31, 2022

Study Registration Dates

First Submitted

August 13, 2020

First Submitted That Met QC Criteria

August 18, 2020

First Posted (ACTUAL)

August 20, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 20, 2020

Last Update Submitted That Met QC Criteria

August 18, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • B-2003-603-304

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endotracheal Intubation

Clinical Trials on group "O"

3
Subscribe